Schedule 13G Filing for Bluejay Diagnostics, Inc.

This Schedule 13G filing, submitted on October 16, 2025, reports the beneficial ownership of Bluejay Diagnostics, Inc. common stock by Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC. The filing indicates that the Reporting Persons collectively own 177,580 shares of Common Stock, representing approximately 9.99% of the outstanding shares. The shares include 175,000 shares held by Intracoastal and 2,580 shares issuable upon the exercise of a warrant held by Intracoastal. The filing also notes that certain warrants held by Intracoastal contain blocker provisions that limit the exercise of these warrants to prevent the Reporting Persons from exceeding specific ownership thresholds. The filing is made under Rule 13d-1(c) and includes a Joint Filing Agreement signed by the Reporting Persons.